Imaging Biometrics Ltd. (IQAIF)
Imaging Biometrics Ltd. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Saint Helier, JE. The stock last traded at $0.02, up 0.00% on the session, giving a market capitalisation of $4.9M. On trailing twelve-month figures it carries a trailing P/E of -8.05, a net margin of -43.6%. Its beta of 2.59 implies it has historically moved more than the broad market.
IQ-AI Limited is dedicated to advancing healthcare by developing and commercializing cutting-edge medical software and associated services. In March 2018, the company expanded its portfolio by acquiring Imaging Biometrics, LLC (IB), a Wisconsin, USA-based firm specializing in medical imaging software. Imaging Biometrics not only offers regulatory consulting but also delivers a variety of medical technology solutions, boasting a robust suite of neuroimaging products. These sophisticated analytical tools empower clinicians, enabling them to diagnose and treat diseases with enhanced precision and confidence. Notably, the integration of IB marked IQ-AI's second strategic acquisition within the medical imaging domain, following its purchase of Stone Checker Software Ltd in 2017.
Imaging Biometrics Ltd. is most often compared with the following Healthcare names: